Jose Gomez-Marquez

1
IIH  Global  Health  Device  
Development  Model  

Our community ecosystem is aimed

APD provides a pathway to
at accelerating ideation and
get the ideas to products.
contributing distributed resources.

2
IIH  Opportunity  Sectors  
 Vaccines  
 Tech  for  disabilities  
 Mom  and  baby  health  
 Diagnostics  
 Therapy  enhancements  
 Surgical  tools  
 Personalized  medical  devices  
 Chronic  conditions  
 Appropriate  Lab  Instrumentation  
 Information  Systems  

3
HLab  
  IIH  network  of  HLabs  are  an  important  part  of  our  ability  to  produce  world-­‐
class  medical  technologies  for  developing  world  countries.  Our  access  to  
rapid  prototyping  facilities,  micro-­‐machining,  biomedical  labs,  software  
development  clusters  combined  with  the  talented  developers  who  run  them  
make  HLabs  the  new  Menlo  Park  for  Global  Health.    
  MIT  
  Essential  prototyping  facilities  
  3  Machine  Shops,  3-­‐D  Printers,  Laser  cutters,  Machine  Shops,  Electronics,  
Mobile  technology  
  Outsource:  partners,  competitions,  classes  
  Karachi  
  Informatics,  mobile  technology,  software  
  Managua  
  Laboratory  testing  and  diagnostic  co-­‐development  
  2009  D-­‐Lab  Health  impact  

4
By  the  numbers  
 2  Years  Old  
 12  collaborative  country  sites  
 Peru,  Pakistan,  Nicaragua,  Guatemala,  India,  Ghana,  
Nepal,  Honduras,  Tanzania,  Venezuela,  Ethiopia,  
Uganda    
 20+  PIs  working  across  7  fields  
 22  active  technology  projects  
 3  ongoing  field  trials  

5
A  Global  Collaboration  Footprint  

6
80-­‐90%  
of  all  medical  
equipment  in  
developing  countries  
are  secondhand  

80%    
fail  in  the  first  
6  months.  
How  We  Measure  the  Impact  Viability  of  our  
Solutions  
Appropriate technology often requires a nuanced approach to design that
combines simple solutions, elegant technologies and robust engineering to make
technologies survive the rigors of the field. This often produces a highly tailored
approach to each solution that is difficult to standardize across sectors and
across individuals.

We have taken steps to identify the most important tensions that exist in
appropriate biomedical technologies seen through the design lens. By mapping
RESOURCE INVESTMENT and IMPACT along a X-Y spectrum, we can anticipate
how appropriate our solution is against conventional approaches. We call this the

Impact  
Global Health Innovation Compass.

Resource  Investment  

8
The  Global  Health  Innovation  Compass  
Affordable/
High Impact Expensive/
High Impact

Impact  
Investment  &  
Resources  

Affordable/ Expensive/
Low Appropriate Impact Low Appropriate Impact

9
The  Global  Health  Innovation  Compass  
Affordable/
High Impact Expensive/
High Impact

Our goal and strategy is to identify

and work within catalyzing
technologies (shown in purple
arrows) that are able to take the
capabilities of one paradigm state into
the more Affordable and High Impact
states. Sometimes, it may be a better
mobile phone language that take the
capabilities of a laptop computer into
the portability of a mobile phone. Or
perhaps, it may advanced digital
microfluidics technology that takes the
diagnostic capabilities only found into
hospital, and transfers them to the
field in a rugged, disposable device.
Often it’s the combination of existing
technologies that marry accuracy and
portability into a distributed system.

Affordable/ Expensive/
Low Appropriate Impact Low Appropriate Impact
 A  Focus  on  Applied  Technology  to  
get  Products  to  Patients    
IIH provides researchers at MIT and
other institutions to work on applied
technology projects that have a real
impact in the field. This requires a
comprehensive look at the solution.
The picture illustrates the value-chain
of a microfluidic diagnostic product
compared to the academic
publishing opportunities.

We recognize the opportunities to

disseminate the research are
important and we continue to pursue
those to advance the field. However, PRODUCT!
our group puts a premium on developing
the concepts, prototypes, products, and
dissemination strategy to get solutions to the healthcare arena. We accomplish this by working with
stakeholders in the field on a daily basis. It keeps the timeline of our ideas aligned with the rapid pace of
need in the field.

Source: LabChip, 2007, 7, 41–57

11
From  Prototype  to  the  Field  
IIH  SafeTrial  
  Through  the  IIH@  MIT  SafeTrial  program,  we  have  the  opportunity  
to  conduct  clinical  and  engineering  field  trials  in  Tanzania,  
Nicaragua  and  Pakistan  for  member  technologies.  The  IIH  SafeTrial  
program  allows  the  technology  to  be  tested  at  a  very  low  cost  
compared  to  traditional  testing  facilities  under  the  direction  of  
experienced  public  health  professionals.  
  This  is  an  important  distinction  between  IIH  and  other  global  
health  centers.  Our  ability  to  rapidly  prototype  concepts,  take  
them  to  the  field  for  data  acquisition,  and  iterate  provides  a  
pathway  in  which  we  can  show  early  results,  adoption  information,  
and  market  feasibility.  This  gets  our  designs  closer  to  
commercialization  that  our  counterparts  in  other  institutions.    

12
Field  Organizations  for  Technology  Testing  and  
Implementation  
Nicaragua (H-Lab Managua, MIT IIH) Pakistan (H-Lab Karachi, MIT IIH)

13
Field  Organizations  for  Technology  Testing  and  
Implementation  
Cambodia (Cambodian Health Committee): Indonesia
(International Organization of Migration):
Siem-Riep Provincial Hospital
Phnom Penh (2 sites: KSFH & Calmette) Cut Nyak Dhien Hospital
Takeo Provincial Hospital
Community Clinics (Puskesmases)
Svay Rieng Provincial Hospital

14
Field  Organizations  for  Technology  Testing  and  
Implementation  
Ethiopia (Global Health Committee):
Addis Ababa

15
IIH  Representative  Technologies  

16
Drug  Delivery  
Aerovax  
The Aerovax System was designed as a go-anywhere inhalable drug and vaccine delivery technology designed for mass immunization of
remote populations.
Diagnostics  
S.N.A.P  
Simple  Nucleic  Acid  Processing  
A field deployable DNA collection device. An IIH H-Lab team worked on a field deployable solution for Boston University researcher’s
bench-based microfluidic sample collection tool that is now under further development by researchers MIT, Boston University, and
designers in California and Ethiopia.

18
Diagnostics   Patients who do not take their medications
cost the American healthcare system $290 billion

XoutTB  
a year in increased medical spending.
--- New England Healthcare Institute, August 2009

A  Mobile-­‐enabled  diagnostic  medication  compliance  platform  

A new penny-a-day test is ensuring adherence to Tuberculosis medications using a smart combination of mobile phones, diagnostics, and
creative incentives.

19
Diagnostics   Patients who do not take their medications
cost the American healthcare system $290 billion

XoutTB  
a year in increased medical spending.
--- New England Healthcare Institute, August 2009

A  Mobile-­‐enabled  diagnostic  medication  compliance  platform  

A new penny-a-day test is ensuring adherence to Tuberculosis medications using a smart combination of mobile phones, diagnostics, and
creative incentives.

20
Diagnostics  
Microfluidic  System  for  Monitoring  Sepsis  
at  the  Point-­‐of-­‐Care  

Dr. Catherine Klapperich, an Assistant Professor of Engineering at Boston University

is an IIH affiliate and CIMIT-backed researcher.

Need and Impact

Sepsis is a systemic response to an infection that can be bacterial, viral, fungal or
parasitic in origin and its diagnosis is based on patient’s history and
presentationCurrent standard of care for sepsis require blood cultures that can take
days to completeCurrent FDA approved “rapid tests” have reasonable sensitivity and
specificity, but not the causative organism

Solution and Innovation

Develop rapid, point-of-care test to monitor sepsisQuantify nucleic acids in blood by
combining novel microfluidic nucleic acid isolation with on-chip quantitative PCR
Design assay to determine, in parallel, whether infection is bacterial (gram positive
or gram negative) or fungal

21
Diagnostics  
Microfluidic  System  for  Monitoring  Sepsis  
at  the  Point-­‐of-­‐Care  

Jose Trevejo, MD, PhD, BIDMC and Preshious Rearden, PhD, Draper

Need and ImpactTuberculosis (TB) remains a major public health problem worldwide with
approximately 8 million new cases and >2 million deaths per yearMajor obstacle is the lack of
point-of-care diagnostics for TB with high sensitivityNo real-time, reliable, inexpensive,
portable detection deviceSolution and InnovationDevelop real-time volatile analysis system
(breath analyzer) for TB detectionLeverage and apply novel differential mobility spectrometer
that has a highly sensitive, portable gas sensors for detection at very low
concentrationsWorld Healthcare Organization (WHO) supported ongoing clinical trials for TB

FAIMS Human Breath Tracing 22

Diagnostics  
Microfluidic  System  for  Monitoring  Sepsis  
at  the  Point-­‐of-­‐Care  

Dr. Catherine Klapperich, an Assistant Professor of Engineering at Boston University is an IIH

affiliate and CIMIT-backed researcher.

• Need and ImpactSepsis is a systemic response to an infection that can be bacterial, viral,
fungal or parasitic in origin and its diagnosis is based on patient’s history and
presentationCurrent standard of care for sepsis require blood cultures that can take days to
completeCurrent FDA approved “rapid tests” have reasonable sensitivity and specificity, but not
the causative organism

Solution and Innovation

Develop rapid, point-of-care test to monitor sepsisQuantify nucleic acids in blood by combining
novel microfluidic nucleic acid isolation with on-chip quantitative PCR Design assay to
determine, in parallel, whether infection is bacterial (gram positive or gram negative) or fungal

23
Maternal  and  Infant  Health  
Car  Parts  Incubator  

Dr. Kristian Olson is the Program Leader for CIMIT’s Global Health Initiative and chief
architect of the Car Parts Incubator project.

Need and ImpactEach year over 4 million infants worldwide die within a month of birth due to
pre-maturity, low birth weight and infectionConventional incubators designed for industrialized
markets can cost over $30,00095% of donated medical equipment ends up broken within five
years and unused due to lack of local training and repair Solution and InnovationBuild a low-
cost, higher performing, safer and effective neonatal isolette for low-resource, rural
settingsDesign and leverage readily locally available automotive partsDevelop and train to be
operated, repaired and maintained with local human resource capacity

24
Cell-­‐phone  Based  
Vibrotactile  Balance  
Visual  
Central  Nervous  
System  
h"p://www.sensory-­‐systems.ethz.ch  

Ves=bular  

h"p://www.infovisual.info/  

Somatosensory   Sensory  Subs=tu=on   h"p://www.soulco.be  

Vibrotac=le    
Electrotac=le  
Auditory  
h"p://www.profeet.co.uk  

25
Cell-­‐phone  Based  
Vibrotactile  Balance  
Body motion is sensed and displayed to the user via vibrotactile cues to the torso  
Connect via
Headphone Jack

External Tactors
(Samsung)
Samsung smart phone
iPhone features Balance trainer with smart phone
- Tri-axial accelerometer - Support ubiquitous balance training device
- Interface tactor driving hardware with 32 pin
- Visual display and Touch screen
connector
- Internal data storage
- Provide winCE operating system that enables to
- SDK development kit build embedded application software

26
Portable  Biofeedback  System  

Battery
Tactor
(Samsung)

MCU

Main objectives
- Improve human motor function in patient populations with
sensory and/or motor deficits
- Support multiple patients via wireless or web-based manner
- Provide clinical or motor learning tasks in physical therapy or 6X5X3.5 cm
sports training

27
Global  Health  Design  Research  
  Noninvasive  dehydration  
detection  
  Approximates  fluid  loss  on  the  order  
of  1-­‐2%  dehydration  by  assessing  
radial  pulse  before  and  after  supine  
to  standing  transition    
  Cell  phone  based  maternal  
health  diagnostic  platform  
  Cell  phone  based  patient  
symptom  recognition  and  
referral  system  

28
Portable  Obstetrics  Exam  Table  

James Bradshaw, Adam Gienapp,

29
Joseph Perosky, Rebecca Rabban
Traditional  Male  Circumcision  Device  

http://current.com/items/89197959/12yr_old_boy_circumcised_with_rusty_knife.htm

  Decrease  HIV  transmission  

  Increase  safe  outcomes  of  
circumcision  
30
Kyle Lemmermen, Phillip Scott, Craig Spencer, Tom Van Wingen
Foldable  Tricycle  Attachment  

31Tran
Brian Holcomb, Alex Klonick, Michael Swift, and Michael
Fall  2009  Design  Projects  

  Low-­‐cost  mechanical  CPAP  machine  

  Clean Water for the World integrated  pump  and
water  purification  system  
  Low-­‐cost,  low-­‐tech  blood  pressure  measurement  
device  
  Surgical  thoracotomy  simulator    
  Infant  circumcision  device  

32
IIH  Design  Strategies  

33
How  do  we  get  there?  
Design  Strategies  
 Hybridization
 Vintage Technologies + Smart Design/Tech
= New Solutions
 Taking the improvisation and engineering
solutions
 Bottom up observation
 Be trendsetting, not trendy
 Context shifting
 Distributed Systems
 Crowdsourcing
34
A  little  of  the  old,  a  little  of  the  
new  

35
Hybridization  

 Hybridization  

+
Context  Shifting  
Vintage  Technologies  +  Smart  Design  
Improvisation    Design  

Coca Cola Spacer for Asthma

Inhalers
A  Rich  Community  

microfluidics

Collaboration and Diversity Tools

Microfluidics

Solar

Windows Mobile

Neonatal

J2MEE

Tuberculosis

Pulse Ox

40
Our  Community  By  the  Numbers  
Nursing;  6%   Public  Health;  4%  

Industrial  Design;  6%  

Biomedical  
Engineering;  6%   Physicians;  27%  

Biomedical  
Research;  6%  

Business;  14%  

Electrical  
Engineering;  9%  

Policy;  10%   Mechanical  

Engineering;  12%  

41
IIH  Global  Health  Technology:  
Healthcare  Challenges  
Our  Research  Direction  
Collaboration  Opportunities  

42
IIH  Global  Health  Technology:  
Healthcare  Challenges  
Our  Research  Direction  
Collaboration  Opportunities  

43
The  Next  Challenges  
in  Global  Health  Technology  
 Oncology  
 Diabetes    
 Diagnostics  
 Imaging  Solutions  
 Telemedicine  
 Medical  Simulation  
 Rehabilitation  and  Personalized  Orthodics  

44
Oncology  |  Challenges  
  Cancer  now  kills  more  people  in  developing  
countries  than  HIV,  TB  and  malaria  
combined.    

  Key  Drivers:  
  Longer  life  expectancy  -­‐-­‐  cancer  risks  rises  
as  one  ages  
  Adoption  of  modern  lifestyles  (smoking,  
drinking,  sedentary  lifestyles  couples  with  
diets  high  in  fast  and  sugar)  
  Lack  of  early  detection  for  cancers  related  
to  infection,  such  as  human  papillomavirus  
(HPV),  which  is  linked  to  cervical  and  
colourectal  tumours  

45
Oncology  |  Opportunities  
  There is a clear opportunity for applications for early diagnosis, treatment, and palliative care of cancer in the
developing world. In addition to research opportunities, the field is largely untapped as a business opportunity
since most cancer patients constitute the driving force, the working professional class, of developing world
economies. The lack of adequate treatments fosters regional medical tourism afforded only to the wealthy.

Area  of  Care   Opportunity   Technological  Drivers  

The  Programme  of  Action  for  Cancer  Therapy  is  rapidly  expanding  conventional  radiation  
More  than  75%  of  cancer  patients  in   treatment  and  imaging  devices  to  select  pilot  sites  in  the  developing  world.    
Radiotherapy   low  and  middle  income  countries  have  
Development  of  smaller,  portable  radiotherapy  units  could  decentralize  access  to  radiotherapy  
access  to  radiotherapy  treatment  
and  make  it  available  in  more  remote  geographies.  Advances  such  as  ion-­‐induced  nuclear  
radiotherapy  could  prove  pivotal  is  combined  with  appropriate  technological  design  .  

According  to  the  World  Health  

Organization,  two  thirds  of  the  world's   The  Programme  of  Action  for  Cancer  Therapy  is  rapidly  expanding  conventional  radiation  
population  has  little  or  no  access  to   treatment  and  imaging  devices  to  select  pilot  sites  in  the  developing  world.    
Imaging   basic  diagnostic  X-­‐ray  services.    This  
Development  of  smaller,  portable  radiotherapy  units  could  decentralize  access  to  radiotherapy  
has  a  major  impact  in  early  detection  
and  make  it  available  in  more  remote  geographies.  Advances  such  as  ion-­‐induced  nuclear  
of  cancers  which  could  improve  
radiotherapy  could  prove  pivotal  is  combined  with  appropriate  technological  design.  
survival  outcomes.  

46
Diabetes  |  Challenges  
  WHO predicts that developing countries will bear the brunt of this epidemic in the
21st century, with 80% of all new cases of diabetes expected to appear in the
developing countries by 2025.  
  Diabetes is increasing faster in the world's developing economies than in developed
countries. Seven out of ten countries with the highest number of people living with
diabetes are in the developing world. With an estimated 35 million people with
diabetes, India has the world's largest diabetes population.

  Diabetes is a silent epidemic that claims as many lives each year as HIV/AIDS. In
2007, diabetes will cause 3.5 million deaths globally.  
  If present trends persist, by 2025 the majority of people with diabetes in the
developing countries will be in the 45-64 age group.

47
 Diabetes  |  Opportunities  
  Diabetes is a multi-sided healthcare burden that offers many opportunities for impact. Although prevention is ideal, treatment
is needed for those who have already developed this chronic condition. We see opportunities in affordable management and
monitoring, insulin delivery systems, and secondary disease management (diabetic wound care, prosthesis, eye care).

Area  of  Care   Opportunity   Technological  Drivers  

We  have  opted  to  pursue  colormetric  based  assays  for  collerating  

Traditional  glucometers  fail  to  gain  traction  in   glucose  levels.  They  are  more  affordable  that  traditional  
developing  world  markets  because  the   electrochemical  glucose  readers  and  offer  tigher  integration  with  
Management  and   mobile  phone  technology.  Futhermore,  we  see  opportunities  in  
business  model  is  not  adequate.  Patients  
Monitoring   community  based  testing  stations  simliar  to  ATM  machines.  IIH  is  
cannot  afford  the  test  strips  even  if  the  
exploring  one  such  design  called  the  Glucovend  that  encapsulates  all  
glucometer  is  given  freely  to  them.   the  testing  and  diagnostic  technology  in  a  credit-­‐card  size  form  
factor.  

IIH  has  designed  a  series  of  affordable  nebulization  and  inhalation  

devices  that  could  bridge  the  gap  between  developing  world  
According  to  the  British  Medical  Jounal,  only   populations  and  novel  inhalable  therapeutics  such  as  aerosol  insulin.  
about  36%  of  small  towns  in  the  developing   Options  like  these  are  already  in  the  field  such  as  Oralyn  insulin  being  
world  have  reliable  access  to  insulin.   delivered  through  oral  inhalation  in  Ecuador  (not  IIH  affiliated).    
Furthermore,  syringes  remain  the  preferred  
Insulin  Delivery  Systems   choice  for  insulin  delivery,  but  provide  many  
downsides  to  public  health  (80%  of  all  
syringes  in  the  developing  world  are  misused  
leading  to  2.5  MM  Hepatitis  cases  and  up  
250,000  cases  of  HIV  infection)  

48
Imaging  |  Challenges  
  According to the World Health Organization, two thirds
of the world's population has little or no access to
basic diagnostic X-ray services. Additionally, the
World Health Organization estimates that there is a
need for one diagnostic imaging system for every
50,000 people. Medical imaging services are needed
for the diagnosis and management of medical
conditions such as trauma, chest disease (including
tuberculosis), and abdominal ailments.
  Despite decades of efforts aimed at addressing the
problem of limited access to diagnostic imaging, little
progress has been made. A key reason for this has
been the lack of coordination in efforts and funding for
sustainable deployment of the affordable technology
that exists. Infrastructure needs to be created to
include support for these critical components, while
utilizing more modern and advanced imaging
technology.
http://www.healthcareitnews.com/news/new-partnership-give-developing-countries-access-diagnostic-imaging-systems

World Health Imaging Alliance

Society for Imaging Informatics in Medicine

49
Imaging  |  Opportunities  
  There is a clear opportunity for applications for early diagnosis, treatment, and palliative care of cancer in the
developing world. In addition to research opportunities, the field is largely untapped as a business opportunity
since most cancer patients constitute the driving force, the working professional class, of developing world
economies. The lack of adequate treatments fosters regional medical tourism afforded only to the wealthy.

Area  of  Care   Opportunity   Technological  Drivers  

More  than  75%  of  cancer  patients  in  

low  and  middle  income  countries   Digital  X-­‐Ray  technology  is  currently  being  developed  by  researchers    with  endurance,  multi-­‐
X-­‐Rays  
have  access  to  radiotherapy   purpose,  and  affordability  in  mind.  
treatment  

Ultrasound  imaging  offers  major  

benefit  in  antenatal  care.  Thorough  
studies  at  a  global  scale  have  never   New  technologies,  such  as  the  M-­‐Turbo  system    developed  by  Sonosite  in  Seattle,  can  help  
Ultrasound   been  completed.  Qualitative  data   improve  access  to  ultrasound  services.  Ultrasound  images  and  data  are  stored  on  a  USB  flash  
with  field  partners  and  select   memory  stick  and  can  later  be  exported  to  a  computer  or  server.  
publications    point  to  the  imaging  
approach  as  a    

Specialty  practitioners  such  as   The  growing  availability  of  broadband  mobile  connections,  cached  data  links,  and  distributed  data  
radiologists,  cardiologists  and   connectivity  provides  a  solid  platform  for  telemedical  consults.  IIH  companies  such  as  
Diagnostic  Telemedicine   pathologists  are  largely  unavailable   ClickDiagnostics  and  Moca  Mobile  are  providing  important  telemedicine  services  to  bridge  the  gap  
in  rural  areas  due  to  “internal  brain   between  rural  patients  and  knowledagable  specilaists  in  eye  care,  dermatology,  oncology,  and  
drain”   maternal  health.    

50
IIH  Global  Health  Technology:  
Healthcare  Challenges  
Our  Research  Direction  
Collaboration  Opportunities  

51
Click  Diagnostics  

52
Cough  Tracker  

53
RFID  Symptom/Disease  Navigator  

54
Lab-­‐in-­‐a-­‐Box  

55
BioMagnetic  Diagnostics  

56
Mobile  Health  |  Population  Counting  
Signs of life

Can roll out in specific numbers

of “Grids” and then improve confidence
of statistical estimation.

57
Mobile  Health  |  Population  Counting  

58
Mobile  Health  |  Diagnostic  Accessories  

59
Rural  Health  Informatics  
  Large health inequity seen in
Latin America  
  Rural poor are 5x more likely to
die before 60 than non-poor1  
  Financing of rural health systems has
decreased proportionally  

  Technology can be implemented and

improve health care in rural settings  
  Partners In Health (Peru,2 Rwanda, …)  
  Millenium Villages Project (10 countries)  
  Public HIV and TB programs in Brasil3
1.  Casas JA et al Health Disparities in Latin American and the Caribbean,
PAHO, 2001
2.  Fraser HSF et al Evaluating the impact and costs of deploying an electronic
medical record system to support TB treatment in Peru, Proc. AMIA, 2006
3.  Costa AL, de Oliveira MM, Machado Rde O. An information system for drug
prescription and distribution in a public hospital. Int J Med Inform, 2004
Courtesy of
Partners In Health
60
Medical  Informatics|  Rural  Outreach  
  OpenMRS, web-based open source
EMR platform  
  Implemented in over 17 countries  
  Sponsored by Google, WHO, Rockefeller
Foundation, Harvard  
  Specially designed for rural settings  
 Works with or without internet  
 Easily installed and modified  
 Incorporated as part of larger training and GPRS
development initiative  
  CommCare  
  Cell phone based system for providing care  
 Implements clinical algorithms and forms  
  Can connect remote health workers to health
center
61
IIH  Global  Health  Technology:  
Healthcare  Challenges  
Our  Research  Direction  
Collaboration  Opportunities  

62
 IIH  is  an  Ecosystem  of  
Collaboration  with  MIT  as  a  Host  

  Our  members  are  embedded  in  world  class  organizations  willing  to  collaborate  and  
provide  field  insight  
63
Collaboration  Opportunities  
•  D-­‐Lab  sponsorship   •  Support  MIT  students  and   •  Engage  Samsung  engineers  
opportunities   investigators  in  deploying,   and  designers  to  engage  IIH  
•  Academic  and  scholarly   designing,  and  testing  new   researchers  and  their  students  
exchanges   medical  device  technologies   to  integrate  Samsung  
•  Conference  and  Lecture   for  global  health   technologies  into  current  and  
opportunities   future  projects.  
•  Firmware  assistance  
•  Korean  fabrication  
opportunities  

Research  
Academics  
Fellowships  

•  Map  current  IIH  initiatives   •  Investigate  field  opportunities  

against  Samsung  research,   and  demand  for  joint  projects  
business,  and  corporate  social   through  our  network  of  
responsibility  directions   collaborators  in  developing  
•  Provide  appropriate   countries  
technology  analysis  to   •  Launch  engineering  field  trials  
Samsung  ideas  and  projects   for  products    

Research   Field  R&D  and  

Alignment   Deployment  

64
More  Information  
Jose Gomez-Marquez

Program Director

[email protected]

617.674.7516

MIT

32 Carlton Street, Building e34

Cambridge, MA

65